Type 1 diabetes

Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

In this prospective analysis of a type 1 diabetes cohort, a protein signature characterized by inflammatory signaling partially mediated the effect of hyperglycemia on hCAD, while a signature characterized by metabolic processes including lipid catabolism and hormone response was associated with hCAD protection independent of glycemia.

Study context

Population
Childhood-onset (< 17 years) T1D, Pittsburgh Epidemiology of Diabetes Complications cohort; baseline mean age 30, mean diabetes duration 22 years
Participants
417 participants
Exposure
Protein modules and 30-year incident hard coronary artery disease (CAD)
Outcome
Incident hard CAD (hCAD; CAD death, nonfatal MI, revascularization, or blockage ≥ 50%)
Follow-up
30-year
Methodological detailshigh-throughput proteomics, weighted correlation network analysis, causal mediation analysis
  • High-throughput proteomics
  • Weighted correlation network analysis
  • Causal mediation analysis

Main finding

As reported in the abstract

30-year incident hard CAD (hCAD), per eigenvalue SD of protein module · 30 years

Incident hard CAD (hCAD)

151 participants

36.2%

Proportion of total HbA1c effect on hCAD mediated by the inflammatory module

14%

Observational data: associations, not effects.

Further findings

Incident hCAD · 30-year

Participants with incident hCAD
151 (36.2%)

Mediation of HbA1c effect on hCAD

Proportion of total HbA1c effect on hCAD mediated by module 1
14%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort. Cardiovasc Diabetol. Published 26 July 2026. doi:10.1186/s12933-026-03313-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.